Silencing lysine demethylase 5B or employing its inhibitor AS-8351 activates the AMPK signaling pathway, consequently inhibiting BC cell proliferation and migration, offering a new potential therapeutic approach for BC treatment.104. The gene discussed is KDM5B; the disease is breast cancer.